SLC17A6 and breast cancer: In addition, we found that while presynaptic VGluT2 puncta significantly increased (Figure 7C), there were no changes in postsynaptic PSD95 puncta numbers (Figure 7D), suggesting paclitaxel primarily affected presynaptic terminals without changing postsynaptic sites in breast cancer‐bearing mice.